Molly E. Muehlebach

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Geranylgeranyl diphosphate synthase: Role in human health, disease and potential therapeutic target”.

Geranylgeranyl diphosphate synthase: Role in human health, disease and potential therapeutic target

Clinical and Translational Medicine(2023)10.1002/ctm2.1167

N/A

0DataRank · unranked

28 citations

Sarah A. Holstein, Molly E. Muehlebach

Geranylgeranyl diphosphate synthase inhibition impairs osteoclast differentiation, morphology, and resorptive activity

JBMR Plus(2024)10.1093/jbmrpl/ziae133

N/A

0DataRank · unranked

2 citations

Staci L. Haney, Yashpal S. Chhonker, Mamunur Rashid, Daryl J. Murry, Geoffrey A. Talmon +2 more

The role of the unfolded protein response pathway in bone homeostasis and potential therapeutic target in cancer-associated bone disease

Bone Research(2025)10.1038/s41413-025-00457-6

N/A

0DataRank · unranked

4 citations

Sarah A. Holstein, Molly E. Muehlebach

The effects of geranylgeranyl diphosphate synthase inhibitor treatment on osteoblast biology and application in a conditioned media model of myeloma bone disease

Bone Reports(2025)10.1016/j.bonr.2025.101874

N/A

0DataRank · unranked

0 citations

Sarah A. Holstein, Molly E. Muehlebach